Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Lyme Disease Diagnostic Market

ID: MRFR/HC/40363-HCR
200 Pages
Satyendra Maurya
Last Updated: April 24, 2026

Global Lyme Disease Diagnostic Market Research Report: Size, Share, Trend Analysis By Diagnostic Method (Serological Tests, Polymerase Chain Reaction, Direct Detection Tests), By Distribution Channel (Hospitals, Diagnostic Laboratories, Home Care), By End Users (Clinicians, Healthcare Providers, Patients), By Product Type (Test Kits, Reagents, Services) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Lyme Disease Diagnostic Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Diagnostic Method (USD Billion) | |
      1. 4.1.1 Serological Tests | |
      2. 4.1.2 Polymerase Chain Reaction | |
      3. 4.1.3 Direct Detection Tests |
    2. 4.2 Healthcare, BY Distribution Channel (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Diagnostic Laboratories | |
      3. 4.2.3 Home Care |
    3. 4.3 Healthcare, BY End User (USD Billion) | |
      1. 4.3.1 Clinicians | |
      2. 4.3.2 Healthcare Providers | |
      3. 4.3.3 Patients |
    4. 4.4 Healthcare, BY Product Type (USD Billion) | |
      1. 4.4.1 Test Kits | |
      2. 4.4.2 Reagents | |
      3. 4.4.3 Services |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Abbott Laboratories (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Roche Diagnostics (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Thermo Fisher Scientific (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Siemens Healthineers (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Bio-Rad Laboratories (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Quest Diagnostics (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hologic (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Cepheid (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    7. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    8. 6.5 US MARKET ANALYSIS BY END USER |
    9. 6.6 US MARKET ANALYSIS BY PRODUCT TYPE |
    10. 6.7 CANADA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    11. 6.8 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    12. 6.9 CANADA MARKET ANALYSIS BY END USER |
    13. 6.10 CANADA MARKET ANALYSIS BY PRODUCT TYPE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    16. 6.13 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    17. 6.14 GERMANY MARKET ANALYSIS BY END USER |
    18. 6.15 GERMANY MARKET ANALYSIS BY PRODUCT TYPE |
    19. 6.16 UK MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    20. 6.17 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    21. 6.18 UK MARKET ANALYSIS BY END USER |
    22. 6.19 UK MARKET ANALYSIS BY PRODUCT TYPE |
    23. 6.20 FRANCE MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    24. 6.21 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    25. 6.22 FRANCE MARKET ANALYSIS BY END USER |
    26. 6.23 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    28. 6.25 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    29. 6.26 RUSSIA MARKET ANALYSIS BY END USER |
    30. 6.27 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE |
    31. 6.28 ITALY MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    32. 6.29 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    33. 6.30 ITALY MARKET ANALYSIS BY END USER |
    34. 6.31 ITALY MARKET ANALYSIS BY PRODUCT TYPE |
    35. 6.32 SPAIN MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    36. 6.33 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    37. 6.34 SPAIN MARKET ANALYSIS BY END USER |
    38. 6.35 SPAIN MARKET ANALYSIS BY PRODUCT TYPE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    45. 6.42 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    46. 6.43 CHINA MARKET ANALYSIS BY END USER |
    47. 6.44 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
    48. 6.45 INDIA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    49. 6.46 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    50. 6.47 INDIA MARKET ANALYSIS BY END USER |
    51. 6.48 INDIA MARKET ANALYSIS BY PRODUCT TYPE |
    52. 6.49 JAPAN MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    53. 6.50 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    54. 6.51 JAPAN MARKET ANALYSIS BY END USER |
    55. 6.52 JAPAN MARKET ANALYSIS BY PRODUCT TYPE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY END USER |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE |
    64. 6.61 THAILAND MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    65. 6.62 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    66. 6.63 THAILAND MARKET ANALYSIS BY END USER |
    67. 6.64 THAILAND MARKET ANALYSIS BY PRODUCT TYPE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    69. 6.66 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    70. 6.67 INDONESIA MARKET ANALYSIS BY END USER |
    71. 6.68 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY END USER |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    78. 6.75 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    79. 6.76 BRAZIL MARKET ANALYSIS BY END USER |
    80. 6.77 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE |
    81. 6.78 MEXICO MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    82. 6.79 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    83. 6.80 MEXICO MARKET ANALYSIS BY END USER |
    84. 6.81 MEXICO MARKET ANALYSIS BY PRODUCT TYPE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY END USER |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY DIAGNOSTIC METHOD |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY END USER |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY DIAGNOSTIC METHOD, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY DIAGNOSTIC METHOD, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY DIAGNOSTIC METHOD, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY PRODUCT TYPE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Diagnostic Method (USD Billion, 2025-2035)

  • Serological Tests
  • Polymerase Chain Reaction
  • Direct Detection Tests

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Home Care

Healthcare By End User (USD Billion, 2025-2035)

  • Clinicians
  • Healthcare Providers
  • Patients

Healthcare By Product Type (USD Billion, 2025-2035)

  • Test Kits
  • Reagents
  • Services

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions